Selective cyclooxygenase-2 inhibition: Biological and clinical effects

被引：0
作者：
Conti, F [1 ]
Spinelli, FR [1 ]
Ossandon, A [1 ]
Valesini, G [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Med, Div Rheumatol, Rome, Italy
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2000年 / 2卷 / 11期
关键词：
cyclooxygenase; COX-2; inhibition; rofecoxib; celecoxib; non-steroidal anti-inflammatory drugs;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：841 / 847
页数：7
相关论文
共 49 条
  • [1] [Anonymous], 1999, AM J MED, DOI DOI 10.1016/s0002-9343(99)00117-5
  • [2] Brater D.C., 1999, AM J MED, V107, P65, DOI [10.1016/s0002-9343(99)00369-1, DOI 10.1016/S0002-9343(99)00369-1]
  • [3] Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
    Brooks, P
    Emery, P
    Evans, JF
    Fenner, H
    Hawkey, CJ
    Patrono, C
    Smolen, J
    Breeveld, F
    Day, R
    Dougados, M
    Ehrich, EW
    Gijon-Baños, J
    Kvien, TK
    Van Rijswijk, MH
    Warner, T
    Zeidler, H
    [J]. RHEUMATOLOGY, 1999, 38 (08) : 779 - 788
  • [4] Cannon GW, 2000, ARTHRITIS RHEUM-US, V43, P978, DOI 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO
  • [5] 2-0
  • [6] Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735
  • [7] Celecoxib - A review of its use in osteoarthritis, rheumatoid arthritis and acute pain
    Clemett, D
    Goa, KL
    [J]. DRUGS, 2000, 59 (04) : 957 - 980
  • [8] Crofford LJ, 2000, ARTHRITIS RHEUM-US, V43, P4, DOI 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO
  • [9] 2-V
  • [10] Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes
    Crofford, LJ
    Tan, B
    McCarthy, CJ
    Hla, T
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (02): : 226 - 236
12345